Shares of Edgewise Therapeutics, Inc. (EWTX) have gained 4.6% over the past four weeks to close the last trading session at $17.28, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$26.40 indicates a potential upside of 52.8%. The mean estimate comprises five short-term price targets with a standard deviation of $3.65. While the lowest estimate of$23 indicates a 33.1% increase f ...